Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Genelabs Technologies reports phase III results from SLE trial

Oct. 3, 1997

Boston Life Sciences reports phase III results for Therafectin

Oct. 2, 1997

New bradykinin antagonists from Sanofi

Oct. 1, 1997

Cytokine inhibitors presented by SKB

Oct. 1, 1997

Celgene seeks FDA approval for clinical trials with thalidomide for autoimmune disorders

Sep. 29, 1997

Design and synthesis of COX-2 inhibitors related to indomethacin

Sep. 29, 1997

Tachykinin antagonists prepared at Pfizer

Sep. 29, 1997

Amgen seeks partner for inflammation R&D program

Sep. 23, 1997

Generic naproxen introduced in U.S.

Sep. 22, 1997

New NO donor-containing NSAID derivatives from NitroMed

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...